Sign In

Adel Malek

Chief of Neurovascular Surgery at Tufts Medical Center

Dr. Adel Malek is a prominent neurosurgeon and medical innovator who was appointed as the Chief Medical Officer of CereVasc, Inc. in March 2023.1 He brings a wealth of experience and expertise to this role, making him a valuable addition to the company's leadership team.

Professional Background

Dr. Malek holds several distinguished positions in the field of neurosurgery:

  • Chief of Neurovascular Surgery at Tufts Medical Center
  • Director of the Cerebrovascular and Endovascular Division in the Department of Neurosurgery at Tufts Medical Center
  • Professor of Neurosurgery at Tufts University School of Medicine12

Education and Training

Dr. Malek's educational background is impressive:

  • Medical degree from Harvard Medical School
  • Doctorate in medical engineering and Physics from the Massachusetts Institute of Technology
  • Neurosurgical training at Brigham and Women's/Children's Hospital Boston
  • Neurointerventional radiology fellowship at the University of California, San Francisco2

Expertise and Research

Dr. Malek is board-certified in neurosurgery and specializes in:

  • Multi-modal and minimally invasive treatment of brain aneurysms
  • Treatment of arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs)
  • Research on cellular and hemodynamic mechanisms in brain aneurysms and AVMs
  • Development of endovascular technologies2

Role at CereVasc

As the Chief Medical Officer and co-founder of CereVasc, Dr. Malek plays a crucial role in the company's mission to develop novel, minimally invasive treatments for neurological diseases.12 He is a co-inventor of the eShunt endovascular device, which is designed to treat communicating hydrocephalus.1

Dr. Malek expressed his enthusiasm for his role at CereVasc, stating that he is "Grateful to be part of this exciting journey to provide a less invasive endovascular treatment approach to hydrocephalus for our patients!"3

Highlights

Nov 1 · linkedin

Thank you to the organizers of the 30th Congress of the European Society of Gene and Cell Therapy for the opportunity to share the exciting work and innovation in non-invasive next-generation endovascular Gene/ASO/Cell delivery being developed at CereVasc Inc. using the eShunt catheter technology. Grateful to the team of Matthew Gounis, Heather Gray-Edwards and Vania Anagnostakou for help validating CereVasc's novel cerebello-pontine cistern approach! #genetherapy #drugdelivery #esgct2023 #brainhealth #brainresearch #oligonucleotides #celltherapy #brainsurgery #endovascular #neurointervention

Feb 11 · linkedin

Grateful for Dr. Pedro Lylyk, his superb team at Clinica Sagrada Familia in Buenos Aires, Argentina and CereVasc for taking the first step in the minimally invasive percutaneous/endovascular treatment of hydrocephalus.

Related Questions

What is the eShunt endovascular device used for?
What are Dr. Malek's main research interests?
How did Dr. Malek contribute to the development of the eShunt device?
What is the role of the Cerebrovascular and Endovascular Division at Tufts Medical Center?
What is Dr. Malek's educational background?
Adel Malek
Adel Malek, photo 1
Adel Malek, photo 2
Add to my network

Location

Boston, Massachusetts, United States